Loading...
•
Mar 31, 2023
Health Catalyst Q1 2023 Earnings Report
Achieved strong performance exceeding quarterly guidance for revenue and Adjusted EBITDA. Expanded tech-enabled managed services partnership with Allina Health.
Key Takeaways
Health Catalyst reported strong first-quarter results, exceeding the midpoint of its quarterly guidance for both revenue and Adjusted EBITDA. The company also announced a meaningful expansion of its tech-enabled managed services partnership with Allina Health, increasing Allina's recurring revenue to approximately $11 million per year.
Total revenue increased by 8% year-over-year to $73.868 million.
Technology revenue increased by 12% year-over-year to $47.186 million.
Professional services revenue increased by 3% year-over-year to $26.682 million.
Adjusted EBITDA increased significantly to $4.164 million, a 521% increase year-over-year.
Revenue by Segment
Forward Guidance
Health Catalyst provides forward-looking guidance on total revenue and Adjusted EBITDA.
Positive Outlook
- Total revenue between $70.3 million and $74.3 million for Q2 2023
- Adjusted EBITDA between $0.75 million and $4.75 million for Q2 2023
- Total revenue between $290.0 million and $295.0 million for the full year 2023
- Adjusted EBITDA between $9.0 million and $11.0 million for the full year 2023
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...